Becker's Healthcare August 28, 2025
Healthcare groups are condemning the FDA’s decision to issue narrow approvals for COVID-19 vaccines, saying the move will limit access for millions of Americans and raise the risk of severe outcomes ahead of respiratory virus season.
On Aug. 27, the FDA approved updated vaccines targeting newer strains of the virus from Pfizer, Moderna and Novavax. All were approved for individuals 65 and older. However, regulators limited their use among younger adults and children to individuals with at least one condition that puts them at high risk for severe disease.
In past years, COVID shots were broadly recommended for everyone 6 months and older. Medical and public health experts have said the FDA’s move will cause confusion and create...
Today's Sponsors
Today's Sponsor